Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionCarcinoembryonic antigen (CEA)-related cell adhesion molecule 5 (CEACAM5; CD66e) antibody-drug conjugate
Molecular Target Carcinoembryonic antigen (CEA)-related cell adhesion molecule 5 (CEACAM5) (CD66e)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPhase I/II
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today